RespireRx Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012 - 1988
Revenue	0	0	0	0	0	0	0	0.09	0.06	0	Upgrade
Revenue Growth (YoY)	-	-	-	-	-	-	-	40.94%	-	-	Upgrade
Cost of Revenue	0	0	0	0	0	0.01	0.01	0	0	0	Upgrade
Gross Profit	0	0	0	0	0	-0.01	-0.01	0.09	0.06	-0	Upgrade
Selling, General & Admin	1.15	1.86	2.68	1.14	1.49	2.52	5.3	3.62	3.82	0.93	Upgrade
Research & Development	0.43	0.7	0.64	0.6	0.69	1.73	3.18	1.71	0.59	0.21	Upgrade
Other Operating Expenses	-0.07	0	0	0	0	0	0	0	0	0	Upgrade
Operating Expenses	1.58	2.56	3.32	1.74	2.18	4.25	8.47	5.33	4.42	1.14	Upgrade
Operating Income	-1.58	-2.56	-3.32	-1.74	-2.18	-4.25	-8.47	-5.24	-4.35	-1.14	Upgrade
Interest Income	0	0	0	0	0	0	0	0	0	0	Upgrade
Interest Expense	0.6	0.72	0.55	0.4	0.14	0.1	0.59	0.9	0.12	0.06	Upgrade
Other Expense / Income	-0.08	-0.14	0.44	-0.03	-	-0.1	-0.59	-0.9	-0.12	-	Upgrade
Pretax Income	-2.1	-3.14	-4.3	-2.12	-2.59	-4.29	-9.23	-5.96	-2.71	-1.2	Upgrade
Income Tax	-0.08	0.72	0.55	0.4	0.28	0.04	0.76	0.72	-1.65	0.01	Upgrade
Net Income	-2.02	-3.87	-4.85	-2.52	-2.59	-4.29	-9.23	-5.96	-2.71	-1.2	Upgrade
Shares Outstanding (Basic)	111	88	26	0	0	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	111	88	26	0	0	0	0	0	0	0	Upgrade
Shares Change	26.01%	241.69%	6515.29%	16.63%	38.57%	29.73%	57.58%	99.46%	33.81%	32.82%	Upgrade
EPS (Basic)	-0.02	-0.04	-0.19	-6.45	-7.73	-17.75	-49.51	-50.40	-45.65	-27.11	Upgrade
EPS (Diluted)	-0.02	-0.04	-0.19	-6.45	-7.73	-17.75	-49.51	-50.40	-45.65	-27.11	Upgrade
Free Cash Flow	-0.14	-0.96	-0.51	-0.49	-0.43	-0.7	-1.33	-1.3	-0.9	-0.18	Upgrade
Free Cash Flow Per Share	-0.00	-0.01	-0.02	-1.25	-1.28	-2.88	-7.13	-10.98	-15.25	-4.12	Upgrade
Gross Margin	-	-	-	-	-	-	-	98.04%	99.04%	-	Upgrade
Operating Margin	-	-	-	-	-	-	-	-6028.37%	-7059.75%	-	Upgrade
Profit Margin	-	-	-	-	-	-	-	-6859.37%	-4390.57%	-	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-	-	-1494.08%	-1466.37%	-	Upgrade
EBITDA	-1.65	-2.56	-3.32	-1.74	-2.18	-4.24	-8.46	-5.23	-4.35	-1.14	Upgrade
EBITDA Margin	-	-	-	-	-	-	-	-6020.17%	-7057.06%	-	Upgrade
Depreciation & Amortization	390,911	552,787	374,080	215,575	8,378	0.01	0.01	0.01	0	0	Upgrade
EBIT	-390,912.65	-552,789.56	-374,083.32	-215,576.74	-8,380.18	-4.25	-8.47	-5.24	-4.35	-	Upgrade
EBIT Margin	-	-	-	-	-	-	-	-6028.36%	-7059.75%	-	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.